Indianapolis

Indiana Governor Signs New Law Easing Pain Pump Prescription Rules for Chronic Sufferers

AI Assisted Icon
Published on May 29, 2025
Indiana Governor Signs New Law Easing Pain Pump Prescription Rules for Chronic SufferersSource: Indiana House Republicans

In a ceremonial gesture, Indiana Governor Mike Braun put pen to paper recently, signing into law a measure designed to ease the rigors for chronic pain patients managing their care. Authored by State Representative Bob Behning of Indianapolis, the new law extends a helping hand to those reliant on implanted pain pumps for relief. Chronic pain, a specter that haunts many, can indiscriminately ensnare individuals in a relentless grasp, and this legislative effort serves to temper its hold.

Behning, himself acquainted intimately with the relentless nature of such pain following an automobile accident in 2002, championed this cause from a place of personal understanding. This signature by the Governor signals a shift in protocol, allowing to now prescribe certain opioids on 180-day cycles for those using implanted delivery systems—a stark contrast to the previous 90-day limit imposed by the Indiana Scheduled Prescription Electronic Collection and Tracking (INSPECT) program. By easing these regulations, Behning's House Enrolled Act 1200 promises to alleviate some of the burdens shouldered by chronic pain sufferers.

The drive behind Behning's legislation springs from his own journey navigating the tribulations of chronic pain treatment. With a history of back surgery and subsequent enduring pain, the Indianapolis lawmaker was well-versed in the daily complications such conditions wrought, as reported by Indiana House Republicans. "The change in my life has been dramatic," Behning explained, touting the near elimination of side effects once the subdermal opioid delivery system was introduced into his treatment protocol.

Amidst the national clamor and scrutiny over opioid prescriptions, Behning's law aims to carefully balance the necessity of access against the potential for addiction. "There's rightly been a lot of concern about opioid addiction and the need for restrictions on their use," acknowledged Behning. His belief, grounded in the premise that these pumps deliver controlled doses that minimize the risk of abuse, became the cornerstone of legislation designed to both protect and empower patients.